Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
A lot of us in the same boat, the problem is at the moment is that world governments believe Coronavirus is a done deal whereas we know this is most probably the calm before the storm. Deltacron is out there and there is likely to be some unknown variants doing the rounds.
The problem is with testing reducing and PCR's vanishing, it is likely another variant will go undetected until it again spirals out of control. Still believe Synairgen have a great product, just a shame the Sprinter trial was messed up with participants taking other medications as well.
Activ-2 P2 results will provide a boost for SP when they arrive as otherwise they would have never considered moving to P3 and suspect this will be picked up again later this year.
Not all doom and gloom, just need to have patience.
LSE should really show unknown on all trades as they are guessing most of the time as anyone using this site knows...
Those big trades were buys though, expect another TR-1 soon (prices this low so close to P3 results, amazing)
The new Ceo will hopefully lay out a strategy that larger investors will buy into.
Having run a business for nearly 30 years I realise the most important thing is your product and ensuring this is the best in market,the money follows.
Phe have a great product, once its up and running the money will follow. A great job to have, push forward existing and new opportunities and the rest will fall into place.
Actually getting councils on board would be a great achievement as some have incinerators so just need to modify for DMG
WHO have said they are expecting more variants and there are still thousands of people dying daily. Once SNG P3 results are out and show how many lives can be saved, the demand will be enormous.
You need to remember how many pills that are useless were purchased just before Christmas and since...
Hi Doc, you have to remember that Polygon have a big and influential stake in Synairgen and once the P3 results are in the bigger players will come calling fairly quickly.
The UK are risking herd immunity with Omicron but worryingly so many had covid before, although speaking from personal experience it was my first time.
A drug that can allow people to go on with their lives without worry of dropping dead from covid is priceless to economies otherwise each variant will lead to slow growth bumps every winter...
If Synairgen was a billion $ company the results would be out as they would have no much riding on the results. You are talking about a drug that will knock billions of the large pharma companies as it actually works.
I trust as a smaller company Synairgen are as in July 2020 dotting all the i's and crossing all the t's to ensure when they are launched they don't do what the large pharma's have done and over egg the results.
Currently there is no effective treatment if you get ill with Covid, roll on SNG001.
As for a buyout, it will happen but the SP will have risen so much in the interim it won't matter.
Oh and derampers please go away, your lack of knowledge only makes you look ignorant!